JO
John Oyler (Chief Executive Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $89.3M of ONC (282,921 sh across 16 lots, as filed), executed Jul 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$327.2M
shares × price, as filed
Last traded
Aug 12
Filed Aug 12
Median ADV $130.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $406.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
ONCRecent filings
BGNESALE
BeiGene, Ltd.
View filing →
$10.0M41,210 sh across 9 lots
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $14.6M
58,590 sh across 13 lots
Exec Mar 7 2025
Filed Mar 7 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $10.4M
40,009 sh across 7 lots
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $24.7M
101,000 sh across 12 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET